# Lialda

NDC: 54092-476
Generic name: mesalamine
Labeler / Manufacturer: Takeda Pharmaceuticals America, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, DELAYED RELEASE
Routes: ORAL
Marketing started: 20070116

FDA application: NDA022000

## Active ingredients

- MESALAMINE: 1.2 g/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"54092-476"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=54092-476
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3098a080-be86-4265-9818-7fc4beab77b7